ESSA Pharma Inc
General ticker "EPIX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $75.5M
ESSA Pharma Inc does not follow the US Stock Market performance with the rate: -33.2%.
Estimated limits based on current volatility of 1.6%: low 1.59$, high 1.64$
Factors to consider:
- Current price 21.5% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [2.01$, 4.72$]
- 2024-09-29 to 2025-09-29 estimated range: [2.08$, 4.69$]
Financial Metrics affecting the EPIX estimates:
- Negative: Non-GAAP EPS, $ of -0.60 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -13.69 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0.14
- Negative: Industry operating cash flow per share per price (median), % of -24.49 <= 3.85
- Negative: negative Net income
Short-term EPIX quotes
Long-term EPIX plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $0.33MM | $1.76MM | $0.00MM |
| Operating Expenses | $37.17MM | $36.97MM | $32.13MM |
| Operating Income | $-36.84MM | $-35.22MM | $-32.13MM |
| Non-Operating Income | $0.00MM | $0.00MM | $5.55MM |
| Interest Expense | $0.02MM | $0.01MM | $0.01MM |
| R&D Expense | $24.26MM | $24.41MM | $21.32MM |
| Income(Loss) | $-36.84MM | $-35.22MM | $-26.58MM |
| Taxes | $-0.03MM | $-0.11MM | $0.00MM |
| Profit(Loss) | $-36.81MM | $-35.10MM | $-26.58MM |
| Stockholders Equity | $194.01MM | $167.12MM | $145.63MM |
| Inventory | $0.00MM | $110.61MM | $0.00MM |
| Assets | $198.17MM | $169.51MM | $149.12MM |
| Operating Cash Flow | $-25.42MM | $-28.70MM | $-19.78MM |
| Investing Cash Flow | $-35.01MM | $-52.35MM | $-3.53MM |
| Financing Cash Flow | $141.99MM | $0.25MM | $-0.07MM |
| Earnings Per Share* | $-0.96 | $-0.80 | $-0.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.